Metagenomi IncNASDAQ:MGX
- LAST PRICE6.4800
- TODAY'S CHANGE (%)0.3100 (5.0243%)
- Bid / Lots6.4500/ 1
- Ask / Lots6.5300/ 1
- Open / Previous Close6.2700 / 6.1700
- Day Range
- 52 Week Range
- Volume19,286
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGX |
|---|---|---|
| 09:32 ET | 229 | 6.27 |
| 09:36 ET | 132 | 6.27 |
| 09:43 ET | 200 | 6.45 |
| 09:48 ET | 120 | 6.2799 |
| 09:54 ET | 256 | 6.49 |
| 09:56 ET | 788 | 6.6864 |
| 10:01 ET | 100 | 6.67 |
| 10:12 ET | 100 | 6.66 |
| 10:15 ET | 200 | 6.6364 |
| 10:17 ET | 1286 | 6.65 |
| 10:19 ET | 400 | 6.66 |
| 10:39 ET | 884 | 6.65 |
| 10:46 ET | 100 | 6.66 |
| 10:55 ET | 200 | 6.63 |
| 11:00 ET | 200 | 6.55 |
| 11:20 ET | 449 | 6.54 |
| 11:27 ET | 3770 | 6.4702 |
| 11:29 ET | 772 | 6.55 |
| 11:31 ET | 100 | 6.3418 |
| 11:33 ET | 100 | 6.36 |
| 11:36 ET | 100 | 6.35 |
| 11:38 ET | 100 | 6.35 |
| 11:40 ET | 100 | 6.35 |
| 11:54 ET | 108 | 6.48 |
| 11:56 ET | 2721 | 6.44 |
| 11:58 ET | 100 | 6.41 |
| 12:03 ET | 100 | 6.41 |
| 12:14 ET | 490 | 6.42 |
| 12:23 ET | 425 | 6.46 |
| 12:34 ET | 155 | 6.48 |
Yesterday
DJ Metagenomi Cut to Neutral From Overweight by JP Morgan, from 8:42AM ET on Thursday May 02, 2024 by Dow Jones
8:42AM ET on Thursday May 02, 2024 by Dow Jones
May 1, 2024
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems, from 4:00PM ET on Wednesday May 01, 2024 by Dow Jones
4:00PM ET on Wednesday May 01, 2024 by Dow Jones
Apr 8, 2024
Metagenomi to Present at Upcoming Scientific Meetings, from 8:00AM ET on Monday Apr 08, 2024 by Dow Jones
8:00AM ET on Monday Apr 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Metagenomi Inc | 231.2M | -3.6x | --- |
AVITA Medical Inc | 225.0M | -6.3x | --- |
Genfit SA | 172.9M | -5.6x | --- |
Foghorn Therapeutics Inc. | 260.1M | -2.7x | --- |
Compugen Ltd | 193.4M | -9.8x | --- |
Innate Pharma SA | 189.6M | -23.8x | --- |
Company Information
Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed an expansive and modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. Its platform enables it to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicine.
Contact Information
- Headquarters
- 5959 Horton St, Floor 7EMERYVILLE, CA, United States 94608
- Phone
- 510-871-4880
- Fax
- 302-636-5454
Executives
- Chairman of the Board
- Juergen Eckhardt
- President, Chief Operating Officer
- Jian Irish
- Chief Executive Officer, Founder, Director
- Brian Thomas
- Co-Founder
- Jak Knowles
- Chief Financial Officer
- Pamela Wapnick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $231.2M |
|---|---|
Revenue (TTM) | $44.8M |
Shares Outstanding | 37.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.82 |
Book Value | $5.73 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | 5.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -175.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
